Laboratorios Farmaceuticos Rovi (ROVI)

Index:

IBEX 35

  78.90
   
  • 52 Week High:  84.75
  • 52 Week Low:  49.94
  • Currency: Euro
  • Shares Issued: 51.21m
  • Market Cap:  4,040.47m
  • RiskGrade: 165
  • Beta: 0.55
Select chart: 3 month | 6 month | 1 year
 

3 month

Forecasts

Year Ending Revenue ( m) Pre-tax ( m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 732.85 167.32 252.33¢ 31.3 n/a n/a 92.62¢ 0.0%
31-Dec-26 817.26 199.92 302.89¢ 26.0 1.3 +20% 104.38¢ 0.0%
31-Dec-27 968.38 276.76 419.75¢ 18.8 0.5 +39% 141.57¢ 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Forecast Ratios

Year Ending Revenue/Share Price/Revenue per Share
31-Dec-25  14.31 5.51
31-Dec-26  15.96 4.94
31-Dec-27  18.91 4.17

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue ( m)
31-Dec-2026 n/a n/a n/a 816 833 832
31-Dec-2027 n/a n/a n/a 955 934 951
 
Earnings
31-Dec-2026 n/a n/a n/a 301.56¢ 323.13¢ 321.88¢
31-Dec-2027 n/a n/a n/a 410.00¢ 411.00¢ 424.14¢
 
Dividend
31-Dec-2026 n/a n/a n/a 103.88¢ 109.00¢ 105.75¢
31-Dec-2027 n/a n/a n/a 144.50¢ 136.83¢ 140.33¢
 
Recommendations
Strong Buy 0 0 0 2 0 2
Buy 0 0 0 6 0 4
Neutral 0 0 0 2 0 3
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 0 0 0 10 0 9
 
Average Rec n/a n/a n/a 7.50 n/a 7.22

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

ROVI Market Data

Currency Euro
% Change 0.00 %
52 Week High  84.75
52 Week Low  49.94
Shares Issued 51.21m
Market Cap  4,040.47m
Beta 0.55
RiskGrade 165

What The Brokers Say

Strong Buy 2
Buy 6
Neutral 2
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page